Skip to main content
Fig. 4 | Systematic Reviews

Fig. 4

From: Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis

Fig. 4

Pooled pCR outcome of NAC-treated Asian breast cancer patients according to molecular subtypes and biomarkers. Forest plots describing the random effect ORs and 95% CIs from studies assessing the association of pCR outcome in (A) NAC TP-treated Asian breast cancer patients between TNBC and luminal, combined; (B) between Asian TNBC patients treated with NAC TP and TA; Asian breast cancer patients treated with anthracycline-based chemotherapy with (C) ER; (D) PR; and (E) HER2 biomarkers; (F) Asian breast cancer patients treated with taxane-based chemotherapy and HR biomarker; (G) Asian breast cancer patients treated with TA and ER biomarker. I2 and p-value for X2 of heterogeneity are reported for each group analysis

Back to article page

Systematic Reviews

ISSN: 2046-4053